Skip to main content
. 2016 Jan 17;2(3):180–186. doi: 10.1021/acsinfecdis.5b00136

Figure 3.

Figure 3

Progression of a representative inhibitor class from a preferred human kinase to other ALK chemotypes with T. brucei proliferation activity.